LYB vs UPB · P/E 21, rev $40.30B vs rev $2.4M
LyondellBasell Industries NV (LYB) versus Upstream Bio, Inc. (UPB) — a side-by-side from cached financials, not a winner call.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
Upstream Bio, Inc. (UPB) is a biotechnology company listed on US.
Latest reported LYB revenue for 2024-12-31 was $40.30B. Net income was $1.37B. Revenue was down 2.0% from 2023-12-31 to 2024-12-31. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Latest reported UPB revenue for 2024-12-31 was $2.4M. Net income was -$62.8M. Revenue was down 0.4% from 2023-12-31 to 2024-12-31. UPB currently screens at market cap $407.3M.
LYB currently screens at market cap $19.93B and trailing P/E 21.5. UPB currently screens at market cap $407.3M.
Not investment advice. Open the LYB and UPB stock pages for the full models.
Not investment advice.